Generics Failure-To-Warn Case Enters Oral Arguments
The U.S. Court of Appeals for the Eighth Circuit is set to hear oral arguments Tuesday in a case that will decide whether failure-to-warn product liability claims against generic-drug manufacturers are...To view the full article, register now.
Already a subscriber? Click here to view full article